1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alzamend Neuro Inc (ALZN)
  7. Financials

ALZN

Alzamend Neuro Inc
0.42
0.0499 (13.48%)
Upgrade to Real-Time

Alzamend Neuro Inc. (ALZN) Fundamentals
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
SHARE INFORMATION
Market CapUS$ 38,576,050
Shares Outstanding96,440,124
Float57,892,474
Percent Float60.03%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.15
Latest Fiscal Date2022-04-30
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions45
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months677,016
Institutional Holdings Percent12.3%
Institutional Sold Previous 3 Months2,932,540
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months2,552,000
Insider Holdings Percent4.0
Insider Sold Previous 3 Months500,000
Insider Shares Owned3,871,500
TRADING INFO
52 Week HighUS$ 1.50
52 Week LowUS$ 0.36
52 Week High ChangeUS$ -61.17
21 Day Moving AverageUS$ 0.5233
21 Day Extended Moving AverageUS$ 0.522048
50 Day Moving AverageUS$ 0.5819
50 Day Extended Moving AverageUS$ 0.606085
200 Day Moving AverageUS$ 0.909729
200 Day Extended Moving AverageUS$ 0.938239
10 Day Average Volume151,892
20 Day Average Volume132,062
30 Day Average Volume151,726
50 Day Average Volume208,278
Alpha-0.105869
Beta0.0823
Standard Deviation0.202661
R20.000573
7 Day Price ChangeUS$ -0.101
7 Day Percent Change-20.16%
21 Day Price ChangeUS$ -0.1015
21 Day Percent Change-20.24%
30 Day Price ChangeUS$ -0.17
30 Day Percent Change-29.82%
Month to Date Price ChangeUS$ -0.1369
Month to Date Percent Change-25.5%
Quarter to Date Price ChangeUS$ -0.1649
Quarter to Date Percent Change-29.19%
180 Day Price ChangeUS$ -0.85
180 Day Percent Change-68.0%
200 Day Price ChangeUS$ -0.5709
200 Day Percent Change-58.8%
Year to Date Price ChangeUS$ -0.1649
Year to Date Percent Change-29.19%

Alzamend Neuro Inc. (ALZN) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.60
Total Debt To Equity0.00
Int Coverage-1,982.80
Current Ratio3.20
Leverage Ratio1.20
Quick Ratio2.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.60
Enterprise ValueUS$ 25,348,250
Price to Sales0.00
Price to Free Cash-4.60
PE High Last 5 Years0.00
Price To Book6.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book6.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-150.48
Return on Equity-177.19
Return on Capital-173.21

Alzamend Neuro Inc. (ALZN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBaker Tilly US, LLP
CEOStephan Jackman
Emplyoees7
Last AuditUQ
CIK0001677077
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address3500 Lenox Road NE
Suite 1500
Atlanta, GA 30326
Websitehttps://www.alzamend.com
Facsimile-
Telephone+1 844 722-6333
Email-
Your Recent History
NASDAQ
ALZN
Alzamend N..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230321 22:57:38